Delivery Order SPE2DB20D3101-SPE2DB24FRSV8
Award Date
8/21/24
Potential Completion Date
8/22/24
Potential Value
$9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $10,523.47, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and an ultimate completion date of December 5, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is the...
This federal contract award is for the delivery of BIKTARVY 50-200-25 MG TABLET (30 count) to the Defense Logistics Agency (DLA). The $26,599.01 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 17, 2024 and was awarded on January 16, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $8,132.39 and an ultimate completion date of May 6, 2024. The contract is a delivery order, with a firm fixed price pricing type. The contract was awarded on May 3, 2024 and does not have a set-aside...
This federal contract award is for the delivery of BIKTARVY 50-200-25 MG TABLET (SPE2DB20D1109|SPE2DB24FN80M) to the Defense Logistics Agency (DLA), a defense agency. The $17,592.35 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 14, 2024, with a completion date of March 15, 2024. The contract is a delivery order and has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite...
This federal contract award is for the delivery of BIKTARVY 50-200-25 MG TABLET (30 count) to the Defense Logistics Agency (DLA) Troop Support Medical. The $3,866.42 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, and does not have a set-aside designation. The contract has a performance period through September 9, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award is for the delivery of BIKTARVY 50-200-25 MG TABLET (National Drug Code 6043-0020-30) to the Defense Logistics Agency (DLA). The $9,252.12 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on April 24, 2024, with an ultimate completion date of April 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
The federal contract award is for the pharmaceutical product BIKTARVY 50-200-25 MG TABLET, awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $30,524.28 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of November 5, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BIKTARVY 50-200-25 MG TABLET in quantities of 30 tablets. The contract is a Delivery Order with a Firm Fixed Price of $25,351.56 and an Ultimate Completion Date of August 8, 2024. The contract does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This federal contract award is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product, to the U.S. government. The $8,978.64 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. This contract is a child award under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through...
The federal contract award summarized is for the delivery of the drug BIKTARVY 50-200-25 MG TABLET in quantities of 30 tablets per unit. The $121,990.64 firm fixed price contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 24, 2024. The contract has an ultimate completion date of June 25, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...